
Sustainability by Design
Sanner combines sustainable design, clean energy manufacturing, and its own Sanner BioBase bioplastic to help brands meet sustainability goals within the real-world constraints of healthcare.
Don’t miss our presentations at PODD and CPHI!
- PODD
- Monday, October 27, 2025 – 05:30 PM - 05:45 PM
A Novel Approach to Modelling Injector Performance and Break-Loose Extrusion Force Data
Presenter: Tom Oakley, Springboard, co-presenting with Deep Bhattacharya, Pfizer
- Monday, October 27, 2025 – 05:30 PM - 05:45 PM
- CPHI
- Wednesday, October 29, 2025 – 11:35 AM - 12:05 PM
Rethinking Injector Mechanics – A New Approach to BLEF-Based Modelling
Speakers: Tom Oakley, Springboard, co-presenting with Jay Sayed, Pfizer
- Wednesday, October 29, 2025 – 11:35 AM - 12:05 PM
-
- Wednesday, October 29, 2025 – 12:05 PM - 12:20 PM
Modelling to Market – Enabling Smarter, Faster Injector Development
Speaker: Alex Vasiev, Springboard
- Wednesday, October 29, 2025 – 12:05 PM - 12:20 PM
Meet our experts at the conferences
Feel free to reach out to our sales representatives to arrange a meeting in advance.
Click on the images to send an email.
Transitioning On-Market Products to Sustainable Plastics
In this article, Sanner engineer Kiara Taylor describes the challenges of changing materials to enhance sustainability after a design has been transferred to manufacturing, considering the reasons that might drive such a change, the issues involved and the benefits that can be gained.


Paving the Way for Sustainable Packaging and Device Components
Our proprietary BioBase is a bio-based polymer material that enables our facilities to manufacture more sustainable packaging and medical device components without compromising performance or manufacturability.
How We Drive Product Sustainability

New Product Development
In designing both devices and packaging products, our engineers look to reduce overall carbon footprint and cost by minimizing the number of components and amount of material required.

Clean Energy Manufacturing
Our 300,000 Sq Ft flagship facility in Bensheim Germany utilizes onsite solar and wind power to contribute 15% of the the plant’s total electricity consumption.

Optimizing for Circularity
We analyze products from cradle to grave and assist with life cycle assessments to optimize device designs to reduce overall environmental impact.

Decarbonizing Single-Use Medical & Drug Delivery Devices
Scope 3 emissions from purchased goods and sold products are becoming a growing regulatory pressure for global pharmaceutical and medical device companies and contract manufactured single-use devices sit squarely in the crosshairs.
In this whitepaper, experts from Sanner show how sustainable design and clean energy manufacturing can help brands meet those demands within the real-world constraints of healthcare.
Worldwide production capacity and device development services
Sanner operates a global manufacturing network with a total production space of 28,500 sqm, including 11,000 sqm of cleanroom space (Class 7/8). Our Design Centers of Excellence, Springboard and Gilero, are strategically located in the UK and across the US. Our manufacturing facilities are based in the US, Asia and Europe.
How we can help you
- Capacity for small-batch prototypes and scaling to full production. Our facilities are equipped to handle a wide range of production needs:
- High precision fully electric thermoplastic injection molding capable of handling small shot weights (around 0.1g) up to 64-cavity molds (max. 350T), including 2K molding with thermoplastic elastomers (TPE).
- Manual assembly up to fully automated assembly processes, incorporating mechatronic components for enhanced efficiency and precision.
- End of line packaging for sub-assemblies or finished goods
- Sterilization through trusted external partners, utilizing validated processes to ensure compliance with industry standards.
- Our experience in successfully transferring innovations to production across the EU, US, and China speaks to our ability to bring cutting-edge technologies to global markets. All phases of device development can be supported from our Design and Development Centers of Excellence in both the US and EU.
- Our design transfer processes enable the smoother path to market. We offer end-to-end thinking from development to manufacturing all under one roof to de-risk your project and for a better time to market.
- Our reliability and collaborative working attitude support you in any stage of your project.
Quality control processes and compliance with ISO 13485
Sanner Group facilities are ISO 13485 certified for Design & Development and Manufacturing respectively. Over 250 ISO, AAMI/ANSI standards are used routinely. Our streamlined quality system satisfies the FDA requirements for both the device quality system regulations and the part 210/211 cGMP regulations.















